Literature DB >> 23904199

Increased incidence of retroperitoneal teratomas and decreased incidence of sacrococcygeal teratomas in infants with Down syndrome.

Tetsuko Kobayashi1, Yoshihiro Sakemi, Hironori Yamashita.   

Abstract

Individuals with Down syndrome (DS) have a unique profile of neoplasms, with a higher incidence of leukemias and a lower incidence of solid tumors than seen in the general population. We recently encountered two cases of infants with DS with retroperitoneal teratoma. After reviewing the literature on teratomas in DS, we found that the incidence of retroperitoneal teratomas was higher and the incidence of sacrococcygeal teratomas was lower in infants with DS than in the general population.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Down syndrome; infant; retroperitoneal teratoma; sacrococcygeal teratoma

Mesh:

Year:  2013        PMID: 23904199     DOI: 10.1002/pbc.24693

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Surgical intervention and perioperative risk factors of retroperitoneal teratomas in children: a single institution experience.

Authors:  Shigehisa Fumino; Junnosuke Maniwa; Yuki Takeuchi; Kohei Sakai; Mayumi Higashi; Shigeyoshi Aoi; Taizo Furukawa; Osamu Kimura; Tatsuro Tajiri
Journal:  Pediatr Surg Int       Date:  2016-07-30       Impact factor: 1.827

2.  Sacrococcygeal teratoma in a female newborn with clinical features of trisomy 13: a case report from Central Africa.

Authors:  Toni Kasole Lubala; Olivier Mukuku; Mick Pongombo Shongo; Augustin Mulangu Mutombo; Nina Lubala; Oscar Numbi Luboya; Prosper Lukusa-Tshilobo
Journal:  Int Med Case Rep J       Date:  2015-12-11

3.  Maternal and Birth Characteristics and Childhood Embryonal Solid Tumors: A Population-Based Report from Brazil.

Authors:  Neimar de Paula Silva; Rejane de Souza Reis; Rafael Garcia Cunha; Júlio Fernando Pinto Oliveira; Marceli de Oliveira Santos; Maria S Pombo-de-Oliveira; Beatriz de Camargo
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.